Effect of Education With Mobile App on Metabolic Control in Patients With Type 2 Diabetes

Groups with educational website Participants will be invited to review the site at least once a week. There will be access to social networks and experts' blog for interaction with the patient, as well as an email for doubts with the researchers. The educational site has different educational modules that the patient can review dynamically, reinforcement messages and didactic activities at the end of each module to reinforce the learning acquired. The user will have free access to the educational platform. The educational site will automatically record the number of visits, modules and date of review and will be stored in a database. The above in order to measure adherence to the educational platform.

Groups with educational site and App for reinforcement This group will have access to the App-DM2, which will be installed on the cell phones of patients with diabetes, will have a record for a family member who will serve as a support network for the review of the APP-DM2. It will be compatible with the Android platform. At the beginning of the study the researchers will register each patient and they will receive via SMS message and/or email. The software will be compatible with both Android Smartphone. The investigator will ask the patient to download the application for their initial visit and review it on subsequent visits.

The control group will receive personalized counseling at the beginning of the study, both medical and nutritional, and will continue with their usual medical treatment provided in their family medicine units.

All patients will be scheduled at 3, 6 and 12 months of follow-up for capillary glucose, blood pressure, anthropometry and body composition measurements as follow-up and monitoring measures. In all patients at baseline, 6 and 12 months, venous blood biochemical, clinical, anthropometric and dietary variables will be measured and used for statistical analysis.

Inclusion criteria

• Patients with type 2 diabetes.
• Enrolled as beneficiaries of the Mexican Social Security Institute.
• With HbA1 greater than 7% and less than 13%.
• With and without pharmacological treatment for diabetes (hypoglycemic agents or insulin).
• Who can read and write.
• With ≤ 60 years of age7.
• With ≤10 years of diabetes diagnosis.

Exclusion criteria

• chronic kidney disease with renal replacement therapy
• blindness
• lower limb amputation
• cancer